A service of StreetInsider.com

Most Popular

AAPL 88.93
GOOG 265.99
RIMM 39.80
MSFT 18.61
C 6.45

Recently Added

KWR 10.56
FAS 17.50
CHC 0.56
FAZ 80.00
GNVC 0.43

Gaining Speed

MGG 13.01
OVEN 3.63
FAZ 80.00
AAC 0.03
BZCN 0.05
15.55 +0.00 (0.00%) SGP

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:15.55 Change:+0.00 (0.00%) Prev Close:15.55 Open: 16.37 Days Range:15.40 – 16.51 52 Week Range: 11.97 - 31.53 Volume:16415402 P/E: N/A
EPS:-1.46

Member Comments

No member comments available for SGP


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 12/02/08

Recent Alert on 11/24/08 at 10:48am
Schering-Plough (SGP) Unveils Top-Line Results on SAPHRIS(TM) Showing Efficacy and Safety in Preventing Relapse of Schizophrenia; Reports Preladenant Met Primary Endpoints in Phase II Trial

Schering-Plough Corporation (NYSE: SGP) today revealed top-line results of a long-term Phase III clinical study of its psychopharmacologic agent SAPHRIS(TM) (asenapine) demonstrating efficacy and safety in preventing relapse of schizophrenia. In... Read More

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 12/01/08 at 6:03pm
Form 4 WEINBACH ARTHUR F For: Dec 01
SEC Filing on 12/01/08 at 6:01pm
Form 4 VAN OORDT ROBERT FW For: Dec 01
SEC Filing on 12/01/08 at 5:58pm
Form 4 Thompson Craig B. For: Dec 01

View AllRecent Blog Posts

Blog Posts on 11/27/08 at 3:00am
Johnson & Johnson Is the Latest FDA Casualty
Blog Posts on 11/25/08 at 9:44pm
Finally, A Look at Schering-Plough's Pipeline
Blog Posts on 11/20/08 at 5:44am
Markets Strike Fresh Lows
Blog Posts on 11/14/08 at 11:29am
How Pharma Is Faring in the Financial Crisis